Hypogonadism: all 352 studies
Page 4 of 4. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Open-Label Study of ARD-0403 in Testosterone Deficient MenTerminatedNCT00562731Phase 3
- Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain SyndromesTerminatedNCT00529230
- Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant RecipientsTerminatedNCT00504218
- Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive DisordersCompletedNCT00494169
- Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With HypogonadismCompletedNCT00493961Phase 1
- Effect of Testosterone Replacement on Insulin ResistanceCompletedNCT00487734Phase 4
- Survey of Testosterone Levels in Male Cancer PatientsCompletedNCT00483418
- Prevalence of Hypogonadism in Male Cancer PatientsCompletedNCT00472940
- Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH MenCompletedNCT00470990Not applicable
- Baselines in Reproductive DisordersStatus unknownNCT00456274Not applicable
- Safety of Testosterone Undecanoate i.m. in Hypogonadal MenCompletedNCT00452322Phase 2
- Open-Label Study of ARD-0403 in Testosterone Deficient MenCompletedNCT00448955Phase 3
- Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and DiabetesWithdrawnNCT00440440Phase 4
- Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)CompletedNCT00434824Phase 2
- Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older MenCompletedNCT00431197Phase 1
- Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIRCompletedNCT00425568
- The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile DysfunctionCompletedNCT00421460Phase 4
- Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 InhibitorsCompletedNCT00415571Phase 2
- Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical PracticeCompletedNCT00410306
- Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without DutasterideCompletedNCT00400335Phase 1
- 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal MenCompletedNCT00398580Phase 2
- Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study.WithdrawnNCT00398034Phase 2
- Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low TestosteroneCompletedNCT00392912Not applicable
- Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)CompletedNCT00392756Phase 1
- Investigating the Regulation of Reproductive Hormones in Adult MenCompletedNCT00392457Not applicable
- Pulsatile GnRH in Anovulatory InfertilityStatus unknownNCT00383656Phase 2
- Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal MalesCompletedNCT00372008Phase 2
- Testosterone for Men With Insulin Treated Type 2 DiabetesCompletedNCT00349362Phase 4
- Does Testosterone Improve Function in Hypogonadal Older MenWithdrawnNCT00304213Phase 4
- A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of HypogonadismCompletedNCT00290134Phase 2
- A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)TerminatedNCT00254553Phase 2
- Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors AloneCompletedNCT00244023Phase 3
- Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.CompletedNCT00223860Not applicable
- Assessment of Long Term Treatment With Testosterone Undecanoate in Males With HypogonadismCompletedNCT00220298Phase 3
- Three-Year Trial on a New Testosterone GelStatus unknownNCT00204269Phase 3
- The Effect of Testosterone on Mood and Quality of LifeCompletedNCT00202462Not applicable
- Pharmacokinetic Evaluation of Testosterone Gel (1%)CompletedNCT00193700Phase 1
- Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With HypogonadismCompletedNCT00193661Phase 2
- Bone Density and Serum Testosterone in Male Methadone Maintained PatientsCompletedNCT00170339
- Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80CompletedNCT00163566Phase 2
- The Effects of Testosterone on Prostate Tissue (ACYP-1)CompletedNCT00161486Phase 1
- Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral TestosteroneCompletedNCT00161421Phase 2
- Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesCompletedNCT00141492Phase 2
- Estrogen Treatment (Oral vs. Patches) in Turner SyndromeCompletedNCT00140998Phase 3
- Short-term Effects of Aromatase Inhibition in Obese MenCompletedNCT00138710Phase 3
- Older Men and TestosteroneCompletedNCT00119483Not applicable
- Prevention of Osteoporosis in Men With Prostate CancerCompletedNCT00048841Phase 3
- Leuprolide in Treating Adults With HypogonadotropismCompletedNCT00004438Not applicable
- Leuprolide in Determining the Cause of Gonadotropin DeficiencyCompletedNCT00004426Not applicable
- Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual CycleCompletedNCT00004335
- Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone ReplacementCompletedNCT00001412
- Ovarian Follicle Function in Patients With Primary Ovarian FailureCompletedNCT00001275